Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy

Pinkert, S; Dieringer, B; Klopfleisch, R; Sawatis, K; Van Linthout, S; Pryshliak, M; Tschope, C; Klingel, K; Kurreck, J; Beling, A; Fechner, H

Pinkert, S (reprint author), Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany.; Pinkert, S (reprint author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Pinkert, S (reprint author), Humboldt Univ, Charitepl 1, D-10117 Berlin, Ger

CIRCULATION-HEART FAILURE, 2019; 12 (11):

Abstract

Background: Coxsackie-B-viruses (CVB) are frequent causes of acute myocarditis and dilated cardiomyopathy, but an effective antiviral therapy is still......

Full Text Link